CONTI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 3.627
AS - Asia 2.722
EU - Europa 1.933
SA - Sud America 319
AF - Africa 123
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 2
Totale 8.743
Nazione #
US - Stati Uniti d'America 3.500
SG - Singapore 1.152
CN - Cina 652
VN - Vietnam 361
IE - Irlanda 345
DE - Germania 312
FI - Finlandia 296
SE - Svezia 270
BR - Brasile 231
HK - Hong Kong 189
UA - Ucraina 189
TR - Turchia 133
IT - Italia 127
ZA - Sudafrica 89
CA - Canada 84
NL - Olanda 84
FR - Francia 77
GB - Regno Unito 75
BD - Bangladesh 59
RU - Federazione Russa 43
AT - Austria 38
AR - Argentina 33
IN - India 26
JP - Giappone 26
IQ - Iraq 21
BE - Belgio 20
MX - Messico 16
PL - Polonia 16
CO - Colombia 15
EC - Ecuador 13
UZ - Uzbekistan 12
ES - Italia 11
PH - Filippine 11
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
ID - Indonesia 8
SA - Arabia Saudita 8
CL - Cile 7
EG - Egitto 7
JM - Giamaica 7
KR - Corea 7
TH - Thailandia 7
NP - Nepal 6
PY - Paraguay 6
RO - Romania 6
LT - Lituania 5
PK - Pakistan 5
TN - Tunisia 5
AZ - Azerbaigian 4
EU - Europa 4
KE - Kenya 4
AO - Angola 3
BB - Barbados 3
BG - Bulgaria 3
DK - Danimarca 3
ET - Etiopia 3
JO - Giordania 3
MA - Marocco 3
NI - Nicaragua 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AU - Australia 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
SN - Senegal 2
AL - Albania 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DZ - Algeria 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TC - Turks e Caicos 1
TM - Turkmenistan 1
Totale 8.727
Città #
Singapore 608
Chandler 415
Ashburn 365
Dublin 345
San Jose 324
Jacksonville 302
Santa Clara 286
Hong Kong 184
Beijing 159
Dearborn 158
Izmir 119
Ho Chi Minh City 114
Council Bluffs 101
Munich 100
Boardman 96
Dallas 93
Johannesburg 85
Nanjing 80
Hanoi 79
Ann Arbor 78
San Mateo 72
Princeton 70
Helsinki 66
Lauterbourg 58
Toronto 51
Los Angeles 50
New York 49
Shanghai 48
Wilmington 48
Vienna 38
Bremen 36
Columbus 30
Moscow 28
Nanchang 26
Parma 26
Hebei 25
São Paulo 22
Tokyo 21
Brussels 20
Des Moines 20
Jiaxing 20
Haiphong 19
Jinan 19
Shenyang 19
Buffalo 18
Da Nang 16
Denver 15
Kunming 15
Washington 15
Montreal 14
Tianjin 14
Turku 14
Hefei 13
London 13
Seattle 13
Warsaw 13
Atlanta 11
Frankfurt am Main 11
Brooklyn 10
Houston 10
The Dalles 10
Woodbridge 10
Baghdad 9
Changsha 9
Chicago 9
Bogotá 8
Norwalk 8
Rome 8
Tashkent 8
Trezzano Sul Naviglio 8
Brasília 7
Coventry 7
Phoenix 7
Salvador 7
San Francisco 7
Biên Hòa 6
Can Tho 6
Chennai 6
Mestre 6
Orem 6
Ottawa 6
Grafing 5
Guayaquil 5
Londrina 5
Milan 5
Quito 5
Stockholm 5
Taiyuan 5
Tappahannock 5
Auburn Hills 4
Belo Horizonte 4
Bologna 4
Boston 4
Dubai 4
Düsseldorf 4
Falls Church 4
Hải Dương 4
La Plata 4
Nairobi 4
Nova Iguaçu 4
Totale 5.429
Nome #
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 249
Inhibition of human and avian type A Influenza virus multiplication by NEK-2 treatment 211
Antibodies as a source of anti-infective peptides: an update 201
Abortive replication of influenza A viruses in HeLa 229 cells 200
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 184
Detection of IgA and IgM antibodies to HIV-1 in neonates by radioimmune western blotting. 183
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment. 174
Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect 170
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 162
Peptides from the inside of the antibodies are active against infectious agents and tumours 162
Defective insertion of haemagglutinin as a cause of abortivity of influenza A viruses in HeLa 229 cells. 154
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 150
Effect of coumermycin on influenza A virus replicative cycle. 143
Different patterns of replication in influenza virus-infected KB cells 138
Inhibition of late influenza virus genome expression by diamidinophenylindole. 136
Determinazione di anticorpi anti-HIVmediante un sistema modificato di immunoblotting 134
Biological characterization of FPV, Ulster 73, replicative cycle. 134
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 134
Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus. 132
Control of influenza virus polypeptide synthesis 132
Chromomycin A3 inhibits influenza a virus multiplication in chick embryo fibroblast cells 131
Inhibition of human and avian type A Influenza virus multiplication performed by MESNA 131
Inhibition of multiplication of RNA genome-containing viruses performed by differentconcentrations ofMESNA 129
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 128
Restriction of Influenza virus multiplication induced by PK peptide treatment 128
Aspetti epidemiologici delle batteriemie in Italia: osservazioni effettuate presso il Laboratorio di Microbiologia di Parma 128
Batteriemie da germi anaerobi 128
Cerulenin inhibits production of mature virion particles in chick embryo fibroblasts infected by influenza A viruses. 126
Different patterns of replication in influenza virus-infected KB cells 126
Migration of influenza virus-specific polypeptides from cytoplasm to nucleus of infected cells. 125
The use of radioimmune western blotting to evaluate indeterminate western blotting results in blood donor HIV serodiagnosis 123
CERULENIN INHIBITS THE PRODUCTION OF MATURE VIRION PARTICLES IN CHICK EMBRYO FIBROBLASTS INFECTED BY INFLUENZA A VIRUSES 120
Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection. 120
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 119
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 119
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 118
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT Description not available for EP1596851 (A1) Description of corresponding document: WO2004069235 (A1) 118
USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 117
Effetto di PGA1 e PGJ2 sulla replicazione del virus influenzale 117
Physical characterization of N4-coded messenger RNA 115
Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells 115
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment 113
Inibizione della migrazione della emoagglutinina HA del virus Ulster 73 indotta dalla prostaglandina PGA1 113
Restriction of A/WSN/33 influenza virus multiplication by prostaglandin PGJ2 113
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 112
Inhibition of production of Influenza A viral particles induced by PGA1 treatment 110
Spettro d'azione universale di mimotopi killer antifungini 109
ABORTIVE REPLICATION OF INFLUENZA A VIRUSES IN HELA 229 CELLS 109
Macromolecular synthesis during abortive infection of KB cells by influenza virus 109
Indagine epidemiologica dei microrganismi responsabili di infezioni nosocomiali caratterizzate da batteriemie e/o fungiemie 104
RIWB in comparison with conventional WB, second and third generation ELISA assays for the serodiagnosis of HIV infection 104
Phosphorylation of viral polypeptides in cells infected with influenza virus 103
ROLE OF ACYLATION OF VIRAL HAEMAGGLUTININ DURING THE INFLUNZA VIRUS INFECTIOUS CYCLE 102
GREAT REDUCTION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION BYMELITTIN TREATMENT 102
Inibizione della migrazione della emoagglutininaHA del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGJ2 101
Inhibitory effect of diamidinophenylindole on the replication of influena virus in permissive cellular host. 100
Sepsi da catetere venoso centrale in corso di insufficienza renale. Aspetti epidemiologici e clinici. 100
Role of acylation of viral haemagglutinin during the influenza virus infectious cycle 99
INHIBITION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION PERFORMED BY MESNA. 99
Viral protein synthesis during replication of bacteriophage T1. 98
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT 98
Inibizione della moltiplicazione del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGA1:effetto dose-dipendente 97
Restriction of Influenza virus multiplication induced by treatment with a yeast killer toxin-like synthetic peptide 96
Synthesis of stable RNA in "Escherichia coli" cells infected with N4. 89
Therapeutic Activity of an Anti Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 88
Radio immune Western blotting: a possible solution to indeterminate conventional Western blotting results for the serodiagnosis of HIV infections. 88
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 87
Inhibition of multiplication of RNA genome- containing viruses performed by different concentrations of MESNA. 82
INHIBITION OF LATE INFLUENZA VIRUS GENOME EXPRESSION BY DIAMIDINEPHENILINDOLE 81
Il significato delle colture intraoperatorie della parete e del trombo negli interventi per aneurisma dell'aorta addominale 73
Totale 8.743
Categoria #
all - tutte 29.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022330 0 0 0 17 18 11 48 56 20 36 24 100
2022/20231.389 130 129 77 131 136 180 4 95 458 7 26 16
2023/2024339 22 37 5 8 34 76 31 26 12 8 33 47
2024/20251.570 17 83 89 71 160 255 60 65 219 112 127 312
2025/20262.822 249 228 321 235 438 201 378 70 364 161 114 63
2026/2027489 40 157 136 156 0 0 0 0 0 0 0 0
Totale 8.743